EmmaGuttmanMD
Dermatology • New York, NYSol and Clara Kest Professor, Dermatology, Icahn School of Medicine at Mount Sinai
Dr. Guttman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St Fl 5
New York, NY 10029Phone+1 212-241-9065Fax+1 212-348-7434
Education & Training
Tel Aviv University SacklerClass of 1998
New York Presbyterian Hospital (Cornell Campus)Residency, Dermatology
Certifications & Licensure
FL State Medical License 2020 - Present
NY State Medical License 2007 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Registry for the Atopic Dermatitis Research Network Start of enrollment: 2011 Aug 01
- Immune Reactions in Contact Dermatitis Affected Skin Start of enrollment: 2012 Jan 01
- Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 143 citationsTNF-α Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-α Antagonists to Improve Skin BarrierByung Eui Kim, Michael D. Howell, Emma Guttman, Patricia Gilleaudeau, Irma Cardinale
The Journal of Investigative Dermatology. 2011-06-01 - 54 citationsTwo Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.Jonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, Alan D Irvine, Linda Stein Gold
The New England Journal of Medicine. 2023-03-23 - 17 citationsA phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, John Nia, Peter Hashim
Archives of Dermatological Research. 2023-03-01
Press Mentions
Significant Improvements: A New, Promising Long-Term Treatment for EczemaJanuary 25th, 2023- Eczema: Experimental Drug Shows Promise in Treating Atopic DermatitisJanuary 19th, 2023
- New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term ResultsDecember 9th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
